Reporting Beta Drugs Ltd.
Share
IFRS
Annual
Quarterly
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Цена акции ао | 145.41 | 113.6 | 85.46 | 81.34 | 328.45 | 711.58 | 864.29 | 2009 | 1849.05 | 1849.05 | 1152.47 | 41.28 |
Efficiency
IFRS
Annual
| 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | ||||
| Ebit margin, % | 0 | 0 | ||||
| Рентаб EBITDA, % | 0 | 0 | ||||
| Operation Margin, % | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
